Opiant Pharmaceuticals: Q4 Earnings Insights

Opiant Pharmaceuticals OPNT reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Opiant Pharmaceuticals beat estimated earnings by 1200.0%, reporting an EPS of $0.11 versus an estimate of $-0.01.

Revenue was up $3.88 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.64 which was followed by a 9.78% drop in the share price the next day.

Here's a look at Opiant Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.